4.7 Article

Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 19, Issue 7, Pages 2298-2305

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2011.02.025

Keywords

Acetylcholinesterase inhibitor; beta-Amyloid aggregation inhibitors; Click chemistry; Berberine derivatives; Triazole-containing compounds

Funding

  1. Natural Science Foundation of China [20972198]
  2. Ministry of Science and Technology of China [2009ZX09501-017]

Ask authors/readers for more resources

A series of novel triazole-containing berberine derivatives were synthesized via the azide-alkyne cycloaddition reaction. Their biological activity as inhibitors of both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) were evaluated. Among them, compound 16d, which featured a diisopropylamino substitution at the 4-position of triazole ring, was found to be a potent inhibitor of AChE, with IC50 value of 0.044 mu M. Compound 18d, which beares a butyl at the 4-position of the triazole ring, showed the highest potency of beta-amyloid aggregation inhibition (77.9% at 20 mu M). Molecular modeling studies indicated that the triazole moiety of berberine derivatives displayed a face-to-face pi-pi stacking interaction in a 'sandwich' form with the Trp84 (4.09 angstrom) and Phe330 (4.33 angstrom) in catalytic sites of AChE. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available